$14.15
4.13% yesterday
NYSE, Nov 15, 10:10 pm CET
ISIN
US58502B1061
Symbol
MD

MEDNAX, Inc. Target price 2024 - Analyst rating & recommendation

MEDNAX, Inc. Classifications & Recommendation:

Buy
29%
Hold
71%

MEDNAX, Inc. Price Target

Target Price $15.92
Price $14.15
Potential
Number of Estimates 6
6 Analysts have issued a price target MEDNAX, Inc. 2025 . The average MEDNAX, Inc. target price is $15.92. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 7 analysts: 2 Analysts recommend MEDNAX, Inc. to buy, 5 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the MEDNAX, Inc. stock has an average upside potential 2025 of . Most analysts recommend the MEDNAX, Inc. stock at Hold.

Sales and Margin forecast 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 1.99 2.00
1.15% 0.14%
EBITDA Margin 9.73% 10.58%
18.60% 8.77%
Net Margin -3.14% -5.27%
191.36% 67.69%

7 Analysts have issued a sales forecast MEDNAX, Inc. 2024 . The average MEDNAX, Inc. sales estimate is

$2.0b
Unlock
. This is
0.47% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.0b 0.61%
Unlock
, the lowest is
$2.0b 1.84%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $2.0b 1.15%
2024
$2.0b 0.14%
Unlock
2025
$1.9b 2.77%
Unlock
2026
$2.0b 2.03%
Unlock
2027
$2.1b 4.78%
Unlock

7 Analysts have issued an MEDNAX, Inc. EBITDA forecast 2024. The average MEDNAX, Inc. EBITDA estimate is

$211m
Unlock
. This is
6.15% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$215m 7.97%
Unlock
, the lowest is
$210m 5.41%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $194m 17.66%
2024
$211m 8.89%
Unlock
2025
$228m 8.09%
Unlock
2026
$232m 1.72%
Unlock
2027
$217m 6.45%
Unlock

EBITDA Margin

2023 9.73% 18.60%
2024
10.58% 8.77%
Unlock
2025
11.76% 11.15%
Unlock
2026
11.72% 0.34%
Unlock
2027
10.47% 10.67%
Unlock

3 MEDNAX, Inc. Analysts have issued a net profit forecast 2024. The average MEDNAX, Inc. net profit estimate is

$-105m
Unlock
. This is
59.95% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-101m 61.44%
Unlock
, the lowest is
$-110m 58.17%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-62.7m 192.41%
2024
$-105m 67.87%
Unlock
2025
$117m 211.40%
Unlock
2026
$123m 5.15%
Unlock
2027
$106m 14.32%
Unlock

Net Margin

2023 -3.14% 191.36%
2024
-5.27% 67.69%
Unlock
2025
6.04% 214.61%
Unlock
2026
6.22% 2.98%
Unlock
2027
5.09% 18.17%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -0.73 -1.23
192.41% 68.49%
P/E negative
EV/Sales 0.84

3 Analysts have issued a MEDNAX, Inc. forecast for earnings per share. The average MEDNAX, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-1.23
Unlock
. This is
59.80% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-1.18 61.44%
Unlock
, the lowest is
$-1.28 58.17%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.73 192.41%
2024
$-1.23 68.49%
Unlock
2025
$1.37 211.38%
Unlock
2026
$1.44 5.11%
Unlock
2027
$1.23 14.58%
Unlock

P/E ratio

Current -4.62 156.69%
2024
-11.55 150.00%
Unlock
2025
10.37 189.78%
Unlock
2026
9.86 4.92%
Unlock
2027
11.50 16.63%
Unlock

Based on analysts' sales estimates for 2024, the MEDNAX, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.84 25.37%
2024
0.84 0.04%
Unlock
2025
0.86 2.84%
Unlock
2026
0.85 1.99%
Unlock
2027
0.81 4.57%
Unlock

P/S ratio

Current 0.61 57.44%
2024
0.61 0.48%
Unlock
2025
0.63 2.84%
Unlock
2026
0.61 2.00%
Unlock
2027
0.59 4.57%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today